Clinical Trial Update: Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers [Phase 3]

View source ↗

Summary

Phase 3 safety study of cytisinicline in adult combustible and/or e-cigarette smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Cytisinicline

Snippet

Sponsor: Achieve Life Sciences | Conditions: Smoking Cessation, Vaping Cessation | Phase 3 | Status: COMPLETED